Literature DB >> 6644585

Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.

A Tsuji, T Yoshikawa, K Nishide, H Minami, M Kimura, E Nakashima, T Terasaki, E Miyamoto, C H Nightingale, T Yamana.   

Abstract

The disposition characteristics of beta-lactam antibiotics in rats were investigated, and a physiologically based pharmacokinetic model capable of predicting the tissue distribution and elimination kinetics of these drugs was developed. Protein-binding parameters in rat serum were determined by equilibrium dialysis. Linear binding was found for penicillin G, methicillin, dicloxacillin, and ampicillin; however, nonlinear binding was observed for penicillin V and cefazolin. After intravenous bolus dosing, cefazolin was recovered almost completely in urine and bile, while for the penicillins, penicilloic acid was found to be the major metabolite. Biliary excretion of cefazolin followed Michaelis-Menten kinetics, and no significant inhibition of urinary secretion was observed after probenecid administration. The renal clearance of unbound drug was 0.82 ml/min with a reabsorption ratio (R) of 0.22. Tubular secretion was inhibited for the penicillins by probenecid plasma concentrations of 50 micrograms/ml, resulting in an R-value of 0.32. Erythrocyte uptake, serum protein binding, and tissue-to-plasma partition coefficient (Kp) were measured. Theoretical Kp values were calculated and found to be in good agreement with the Kp values for three of the antibiotics. Plasma and tissue concentrations (lung, heart, muscle, skin, gut, bone, liver, and kidney) were measured as a function of time at various doses for inulin and cefazolin in rats after an intravenous bolus dose, and were found to be in reasonable agreement with concentrations predicted by the model. These correlations demonstrate that the proposed model can accurately describe the plasma and tissue contributions of inulin and cefazolin in the rat and suggest that this model could have utility in predicting drug distribution in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644585     DOI: 10.1002/jps.2600721103

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  35 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Significance of binding to Na,K-ATPase in the tissue distribution of ouabain in guinea pigs.

Authors:  H Harashima; M Mamiya; M Yamazaki; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

3.  Kinetic modeling of ouabain tissue distribution based on slow and saturable binding to Na,K-ATPase.

Authors:  H Harashima; M Mamiya; M Yamazaki; Y Sawada; T Iga; M Hanano; Y Sugiyama
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

4.  Metabolic disposition of DQ-2556, a new cephalosporin, in rats, rabbits, dogs, and monkeys.

Authors:  K Matsubayashi; S Shintani; M Yoshioka; H Tachizawa
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

5.  Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat.

Authors:  Ken-ichi Umehara; Gian Camenisch
Journal:  Pharm Res       Date:  2011-10-20       Impact factor: 4.200

6.  Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver.

Authors:  H Sato; T Terasaki; H Mizuguchi; K Okumura; A Tsuji
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

7.  Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats.

Authors:  Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

8.  ATP-dependent transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) and its xenobiotic taurine conjugate (Z-335-Tau) by rat bile canalicular membrane vesicles.

Authors:  Yoshihiro Kawabata; Emiko Kamada; Shigeru Furuta; Mineo Takei; Tadashi Kurimoto; Kazuho Okudaira; Ryuichiro Nishigaki
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

9.  Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

10.  Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats.

Authors:  M Nadai; T Hasegawa; K Kato; L Wang; T Nabeshima; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.